Introduction: Glycopyrrolate has better antisialagogue effect and does not cross placental barrier; thereby when given immediately before subarachnoid block for elective caesarean section might reduce incidence and severity of nausea and vomiting without affecting neonatal outcome. Methods: In a prospective randomized double blind placebo controlled study, sixty ASA PS I and II patients undergoing elective caesarean section at term were assigned to receive 1 ml of Inj Normal Saline IV or 1 ml (0.2 mg) of Inj Glycopyrrolate.
INTRODUCTION
interfere with the surgical procedure. 1 The incidence of nausea and vomiting is high during pregnancy because of increased concentration of progesterone in the body. Progesterone causes smooth muscle relaxation leading to impaired motility of esophagus, stomach and small bowel. Progesterone decreases lower esophageal sphincter tone. 1 The large gravid uterus contributes to the manifestations of upper gastrointestinal symptoms by mechanically compressing the stomach. 1 Elevated levels of human chorionic gonadotropin (hCG) hormone may play a role in inducing vomiting. 1 Despite regional anaesthesia being found to be effective, safe and anaesthetic of choice for caesarean sections, nausea and vomiting are still present in a significant number of patients. 2 The incidence of nausea and vomiting during spinal anaesthesia is increased by hypotension, a block higher than fourth thoracic segment and the use of anaesthetic adjunts (e.g., intrathecal opioids). 3 The aim of the study is to observe the efficacy of glycopyrrolate on preventing nausea, vomiting (incidence and severity) and on neonatal outcome for caesarean section under spinal anaesthesia.
METHODS
After ethical approval from the Institutional R e v i e w B o a r d a n d D e p a r t m e n t o f Anaesthesiology, Tribhuvan University Teaching Hospital Maharajgunj, Kathmandu, Nepal; a quantitative prospective, randomized, placebo controlled, double blind study was done at preparation room, operating room and post-operative ward. During a study period of 4 months, 60 patients were divided into two groups Group G as Inj Glycopyrrolate and Group N as Inj Normal saline with 30 in each group. The sample size was calculated using p1
(proportion in population 1 in decibel fraction as 0.10), p2 (proportion in population 2 in decibel fraction as 0.40, α (Type I error as 0.05) and power of the study as 0.80. Women with singleton pregnancy with ASA physical status I and II scheduled for elective caesarean section at term were taken as inclusion criteria. Parturients with ASA physical status III and above having contraindications for regional anaesthesia, multiple pregnancy, pregnancy induced hypertension, taking drugs with antiemetic properties within 24 hrs before surgery, placenta previa-Grade III and IV, history of motion sickness, history of past P O N V, p a t i e n t s w i t h h i s t o r y o f gastroesophageal reflux disease, labryinthitis, liver diseases, hyperemesis gravidarum and history of hypersensitivity to the drug to be used in the study were taken as exclusion criteria.
Routine pre-anesthetic evaluation was done one day prior to surgery. Written Informed consent was taken. Patients were kept on fasting for at least 6 hours and premedicated with Tab Ranitidine 150 mg PO at bed time one day before surgery and at 6 am in the morning. In the preparation room baseline systolic blood pressure, diastolic blood pressure and heart rate were recorded. After an intravenous access with an 18 G cannula, a preload of 10 ml/kg of Ringer's lactate was infused over 15 minute. Patient was then shifted to operation theatre and base line monitoring of systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), electrocardiogram (ECG) and oxygen saturation (SPO2) were done and recorded. Patients were randomly assigned to one of two study groups using a sealed envelope technique. Both glycopyrrolate and saline were prepared and given as 1 ml of clear fluid IV either by anaesthesia assistant or nurse on duty
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at operation theatre before performing subarachnoid block and therefore the patient and researcher both were blinded to the randomization.
Subarachnoid block was performed at L2-L3 or L3-L4 space with a 25 gauge spinal needle (Quincke) injecting 2.2 ml of 0.5% hyperbaric bupivacaine. Heart rate, blood pressure (noninvasive), oxygen saturation was monitored & recorded every 5 min interval during the entire operative procedure. Sensory level achieved, as defined by the loss of cold sensation to spirit swab and loss of pin prick sensation, was assessed till adequate sensory level at fourth thoracic (T4) dermatome was obtained. Failure of spinal anaesthesia with conversion to general anaesthesia was excluded from the study. Patients were asked directly using a numerical four point ordinal scale score 19 at 5 min intervals to grade the severity of nausea during intra-operative period, then every 30 min for 4 hr during early postoperative period and finally every 6 hourly till 24 hr of surgery.
Vomiting was assessed as mild (<2 episodes) and severe (>2 episodes). For rescue antiemetics, ondanestron 8 mg IV was given as first rescue antiemetic if at any time during the study period, irrespective of scoring time, two or more episodes of vomiting occurred. Promethazine 12.5 mg IV was given as second rescue drug for refractory emesis not responding to ondansetron. Oxytocin 20 IU was administered intravenously admixed in 500 ml of RL at the rate of 20 ml / min initiated after clamping of umbilical cord. Hypotension which was defined as decrease in systolic blood pressure of 20 % or more from baseline values or absolute decrease to less than 100 mm Hg was treated by fluid bolus 4 ml/kg. If not corrected, mephentermine 6 mg IV was given and repeated after 3 minutes if hypotension persisted. Phenylephrine 50 mcg IV was given as a rescue drug if more than 30 mg of mephentermine was required. Apgar scores were recorded at 1 min and 5 min of birth.
Data was collected and were analyzed using statistical package for social sciences (SPSS) version 17 (Microsoft Corporation). Chi square test, Independent t test and Z test for proportion were used. P value less than 0.05 was considered statistically significant. 
DISCUSSION
Nausea, retching, and vomiting are common during regional anaesthesia for caesarean deliveries especially when the uterus is exteriorized. 4 Various pharmacological and non pharmacological methods have been tried for prophylaxis of nausea and vomiting. However, none of the methods whether used alone or in combination have been found to be fully effective. 5, 6 Glycopyrrolate was chosen in our study because of its easy availability, cost effectiveness and more importantly its impermeability to blood brain barrier and placental barrier. 7, 8 This minimizes the risk of
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Original Article Glycopyrolate in Caesarean; Amatya B R sedation and anticholinergic effects in mother and in neonates which are the main concerns for the parturient. The exact mechanism of glycopyrrolate in preventing nausea and vomiting is not known. However, in addition to favorable antisialogogue effect than atropine, it has been found that glycopyrrolate causes heart rate mediated increase in cardiac output and subsequent reduction in hypotension episodes. 2, 9 It also reduces gastric acidity and increases gastric pH. 10, 11 In our study, during intraoperative period, the severity of nausea and vomiting (3.33% in glycopyrrolate group vs. 60% in normal saline group for nausea and 0 vs. 13.33% for vomiting) was less than that done by Ure D et al (42% in glycopyrrolate group vs. 68% in normal saline group for nausea and 8% vs. 16% for vomiting) probably due to less number of cases (50 cases) in the study done by Ure D et al 5 as compared to 60 cases in our study. The result of our study was similar to that done by Biswas B et al, 12 where they compared g l y c o p y r r o l a t e w i t h m e t o c l o p r a m i d e , dexamethasone and normal saline and found that the incidence of nausea and vomiting was less in glycopyrrolate group than in normal s a l i n e g r o u p ( 1 0 % v s . 4 0 % ) d u r i n g intraoperative period. In our study, the incidence of intraoperative nausea and vomiting had been found to be high after cord clamping which was similar to that done by Albouleish EI et al 13 and Chestnut DH et al. 14 The efficacy of glycopyrrolate as a prophylactic antiemetic during elective caesarean section under spinal anaesthesia of this study was similar to that done by Thakur D et al, 15 In his study, when Inj glycopyrrolate 0.2 mg IV was used in combination with Inj metoclopramide 10 mg IV, the incidence of nausea during intraoperative period was 3.84% and vomiting was 0% that was reduced as The neonatal outcome as determined by Apgar scores was statistically significant in glycopyrrolate group than in normal saline group but clinically insignificant because both the groups had satisfactory Apgar scores. However, in the study done by Ure D et al, 5 and Biswas et al, 12 there were no differences in neonatal Apgar scores between the two groups.
Our study has got few limitations. Firstly, the sample size was relatively small. A study involving a large number of parturient could have given more definite results. Secondly, only the elective cases were included in our study. So, this study had not explained whether glycopyrrolate has significant antiemetic efficacy in parturient undergoing emergency caesarean section or not. Thirdly, the effect of other confounding factors causing nausea and vomiting was not mentioned in this study like u t e r o t o n i c a g e n t s ( o x y t o c i n , m e t h y l 
